Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03489330 · ClinicalTrials.gov registry record
Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use
A clinical trial, sponsored by Midwestern University.
- Completed
- Registry status
- 2,000
- Enrollment target
NCT03489330: Completed study, sponsored by Midwestern University.
NCT03489330 is a clinical trial that has completed, run by Midwestern University. The registered enrollment target is 2,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03489330 has completed, sponsored by Midwestern University.
- COMPLETED
- Registry status
- 2,000 participants
- Enrollment target
Study Summary
In order to decrease inappropriate antibiotic use, drivers of inappropriate use must be identified locally. This study will focus on the MOST inappropriate use, which are defined as 'never events'. Previous work has shown that antibiotic use clusters over time. It is hypothesized that never events also cluster over time. Using electronic data capture strategies, an algorithm will be developed to quickly and accurately identify areas of antibiotic use concern. Secondly, a framework will be developed, utilizing antimicrobial consumption data and captured signals of inappropriate antimicrobial use to provide targets for antimicrobial stewardship efforts.
Primary Outcome
classified as 1) never event, 2) potentially inappropriate, 3) not inappropriate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2014-01-01 |
| Est. Completion | 2020-12-29 |
What the finished NCT03489330 record still lists
NCT03489330 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT03489330 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03489330 about?
NCT03489330 is a clinical study titled "Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use". In order to decrease inappropriate antibiotic use, drivers of inappropriate use must be identified locally. This study will focus on the MOST inappropriate use, which are defined as 'never events'. Previous work has shown that antibiotic use clusters over time. It is hypothesized that never events a...
What is the current status of trial NCT03489330?
This trial is currently completed. The enrollment target is 2,000 participants. The study started on 2014-01-01. Estimated completion is 2020-12-29.
Who is sponsoring clinical trial NCT03489330?
This trial is sponsored by Midwestern University, which has 15 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI